Matches in Nanopublications for { ?s ?p "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP904084.RADfJPSQj-d1CJD78Jfs_Qu8Ks8rh2qLVecCAx7oqq72I130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904084.RADfJPSQj-d1CJD78Jfs_Qu8Ks8rh2qLVecCAx7oqq72I130_provenance.
- NP891863.RALIkthsbhErkCf7C_cBVI15j8ncaORJuINk_JVj-jSdA130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891863.RALIkthsbhErkCf7C_cBVI15j8ncaORJuINk_JVj-jSdA130_provenance.
- NP530516.RA9U7HG__jCR5dVMZBnuL_j0jHap3T5du0lyno9Dy6vEU130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530516.RA9U7HG__jCR5dVMZBnuL_j0jHap3T5du0lyno9Dy6vEU130_provenance.
- NP530509.RAdMts-VQ54MrJyLtbwPiotFZ9w8pwKNjeYp1vRW7lz1Y130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530509.RAdMts-VQ54MrJyLtbwPiotFZ9w8pwKNjeYp1vRW7lz1Y130_provenance.
- assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP530508.RAHTt28qaqU3JcZUIpfwzEh7MA_PKxx9xPxSMZxz-6TTI130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530508.RAHTt28qaqU3JcZUIpfwzEh7MA_PKxx9xPxSMZxz-6TTI130_provenance.
- assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP904105.RAKwGGEXE4b9PCl0HxIagI-x4MftQqDBwjU_x5pELJOPU130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904105.RAKwGGEXE4b9PCl0HxIagI-x4MftQqDBwjU_x5pELJOPU130_provenance.
- NP949797.RAqZj3-tX8Htn5eSehca7yOpv9xvt-EbQzZjTQPg75-28130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949797.RAqZj3-tX8Htn5eSehca7yOpv9xvt-EbQzZjTQPg75-28130_provenance.
- NP949798.RAqKgvl5ODosqDNWAIlM1xgKI8idphQRTcJKWPSDaprmo130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949798.RAqKgvl5ODosqDNWAIlM1xgKI8idphQRTcJKWPSDaprmo130_provenance.
- NP904110.RAtfHz--RSNDfo_UQXWjtLz7ur2shoRO_yWJZP_BCYCFM130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904110.RAtfHz--RSNDfo_UQXWjtLz7ur2shoRO_yWJZP_BCYCFM130_provenance.
- NP530514.RAtRMxCkwLj26j7kq_iZFqyYYtRDrHCxT5KBXF8QvJ0P0130_assertion description "[Testis-specific gene antigen (TSGA10) is expressed in fetus, testis and frequently in human solid cancers and acute leukemias, making it a candidate for immunotherapy and for detection of minimal residual disease (MRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530514.RAtRMxCkwLj26j7kq_iZFqyYYtRDrHCxT5KBXF8QvJ0P0130_provenance.